SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹272 Cr | ₹277 Cr | ₹182 Cr | ₹140 Cr | ₹87 Cr |
What is the latest Total Current Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹272 Cr |
| Mar2024 | ₹277 Cr |
| Mar2023 | ₹182 Cr |
| Mar2022 | ₹140 Cr |
| Mar2017 | ₹87 Cr |
How is Total Current Assets of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹272 Cr | -1.65 | |
| Mar2024 | ₹277 Cr | 52.47 | |
| Mar2023 | ₹182 Cr | 29.96 | |
| Mar2022 | ₹140 Cr | 61.55 | |
| Mar2017 | ₹87 Cr | - | |
Compare Total Current Assets of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,337.6 Cr | 2.1% | -3% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 2.1% |
-3% |
-25.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses